Willingness to use syringe service programs and safe consumption sites among methadone patients with histories of injection drug use in a small Midwest community

References

• Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, Kennedy GE, Des Jarlais DC. 2013. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 17(9):2878–2892.
   PubMed Web of Science ®Google Scholar
• Andersson HW, Wenaas M, Nordfjaern T. 2019. Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances. Addict Behav. 90:222–228.
   PubMed Web of Science ®Google Scholar
• Andrews B, Qian M, Valentine JD. 2002. Predicting depressive symptoms with a new measure of shame: The experience of shame scale. Br J Clin Psychol. 41(Pt 1):29–42.
   PubMedGoogle Scholar
• Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ. 2014. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 43(1):235–248.
   PubMed Web of Science ®Google Scholar
• Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, Mimiaga MJ, Saitz R, Bazzi AR. 2019. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 198:80–86.
   PubMed Web of Science ®Google Scholar
• Bixler D, Corby-Lee G, Proescholdbell S, Ramirez T, Kilkenny ME, LaRocco M, Childs R, Brumage MR, Settle AD, Teshale EH, et al. 2018. Access to syringe services Programs – Kentucky, North Carolina, and West Virginia, 2013-2017. Morb Mortal Wkly Rep. 67(18):529–532.
   PubMed Web of Science ®Google Scholar
• Bouvier BA, Elston B, Hadland SE, Green TC, Marshall BD. 2017. Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study. Harm Reduct J. 14(1):13–19.
   PubMedGoogle Scholar
• Bozinoff N, Anderson BJ, Bailey GL, Stein MD. 2018. Correlates of stigma severity among persons seeking opioid detoxification. J Addict Med. 12(1):19–23.
   PubMed Web of Science ®Google Scholar
• Canary L, Hariri S, Campbell C, Young R, Whitcomb J, Kaufman H, Vellozzi C. 2017. Geographic disparities in access to syringe services programs among young persons with hepatitis C virus infection in the United States. Clin Infect Dis. 65(3):514–517.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention [CDC]. 2020. The drug overdose epidemic: behind the numbers. U.S. Department of Health and Human Services; [accessed 2020 Nov 16]. https://www.cdc.gov/drugoverdose/data/index.html.
   Google Scholar
• Craine N, Hickman M, Parry JV, Smith J, McDonald T, Lyons M. 2010. Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. J Public Health. 32(3):328–335.
   Google Scholar
• Crapanzano KA, Hammarlund R, Ahmad B, Hunsinger N, Kullar R. 2019. The association between perceived stigma and substance use disorder treatment outcomes: a review. Subst Abuse Rehabil. 10:1–12.
   PubMed Web of Science ®Google Scholar
• DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E. 2011. Injection drug use cessation and use of North America's first medically supervised safer injecting facility. Drug Alcohol Depend. 113(2–3):172–176.
   PubMed Web of Science ®Google Scholar
• DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. 2012. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 38(1):55–62.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. 2020. Expansion of syringe service programs in the United States, 2015-2018. Am J Public Health. 110(4):517–519.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. 2015. Syringe service programs for persons who inject drugs in urban, suburban, and rural Areas – United States, 2013. Morb Mortal Wkly Rep. 64(48):1337–1341.
   PubMed Web of Science ®Google Scholar
• Fong C, Mateu-Gelabert P, Ciervo C, Eckhardt B, Aponte-Melendez Y, Kapadia S, Marks K. 2021. Medical provider stigma experienced by people who use drugs (MPS-PWUD): development and validation of a scale among people who currently inject drugs in New York City. Drug Alcohol Depend. 221:108589.
   PubMed Web of Science ®Google Scholar
• Goedel WC, King MRF, Lurie MN, Galea S, Townsend JP, Galvani AP, Friedman SR, Marshall BDL. 2020. Implementation of syringe services programs to prevent rapid human immunodeficiency virus transmission in rural counties in the United States: a modeling study. Clin Infect Dis. 70(6):1096–1102.
   PubMed Web of Science ®Google Scholar
• Harris RE, Richardson J, Frasso R, Anderson ED. 2018. Perceptions about supervised injection facilities among people who inject drugs in Philadelphia. Int J Drug Policy. 52:56–61.
   PubMed Web of Science ®Google Scholar
• Health Resources & Services Administration 2020. Data from: FORHP eligible ZIP codes [dataset]. U.S. Department of Health and Human Services. [accessed 2020 Oct]. https://www.hrsa.gov/rural-health/about-us/definition/datafiles.html.
   Google Scholar
• Jackson County Clerk. 2020. Election results archive: 2020 election results; [accessed 2021 May 10]. https://www.co.jackson.mi.us/1798/Election-Results-Archive.
   Google Scholar
• Kerman N, Manoni-Millar S, Cormier L, Cahill T, Sylvestre J. 2020. “It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health. Drug Alcohol Depend. 213:108078.
   PubMed Web of Science ®Google Scholar
• Kilmer B, Taylor J, Caulkins JP, Mueller PA, Ober AJ, Pardo B, Smart R, Strang L, Reuter PH. 2018. Considering heroin-assisted treatment and supervision drug consumption sites in the United States. RAND Corporation. https://www.rand.org/pubs/research_reports/RR2693.html.
   Google Scholar
• Klein KS, Glick SN, Mauro PM. 2020. Anticipated use of a supervised drug consumption site among syringe services program clients in King County, Washington: assessing the role of opioid overdose and injection behavior. Drug Alcohol Depend. 213:108121.
   PubMed Web of Science ®Google Scholar
• Kolak MA, Chen YT, Joyce S, Ellis K, Defever K, McLuckie C, Friedman S, Pho MT. 2020. Rural risk environments, opioid-related overdose, and infectious diseases: a multidimensional, spatial perspective. Int J Drug Policy. 85:102727.
   PubMed Web of Science ®Google Scholar
• Kral AH, Lambdin BH, Wenger LD, Davidson PJ. 2020. Evaluation of an unsanctioned safe consumption site in the United States. N Engl J Med. 383(6):589–590.
   PubMed Web of Science ®Google Scholar
• Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. 2010. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 110(1-2):160–163.
   PubMed Web of Science ®Google Scholar
• Krüsi A, Small W, Wood E, Kerr T. 2009. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care. 21(5):638–644.
   PubMed Web of Science ®Google Scholar
• Lancaster KE, Cooper HL, Browning CR, Malvestutto CD, Bridges JF, Young AM. 2020. Syringe service program utilization, barriers, and preferences for design in rural Appalachia: differences between men and women who inject drugs. Subst Use Misuse. 55(14):2268–2277.
   PubMed Web of Science ®Google Scholar
• León C, Cardoso L, Mackin S, Bock B, Gaeta JM. 2018. The willingness of people who inject drugs in Boston to use a supervised injection facility. Subst Abus. 39(1):95–101.
   PubMed Web of Science ®Google Scholar
• Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. 2011. Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 377(9775):1429–1437.
   PubMed Web of Science ®Google Scholar
• Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. 2013. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 91(2):102–123.
   PubMed Web of Science ®Google Scholar
• McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, Sherman SG. 2018. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 111:73–77.
   PubMed Web of Science ®Google Scholar
• Michigan Department of Health & Human Services. 2019. Data from : Opioid overdose deaths [dataset]. [accessed 2021 Aug]. https://mi-suddr.com/opioids/
   Google Scholar
• Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. 2002. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 79(2):257–265.
   PubMed Web of Science ®Google Scholar
• Moses TE, Woodcock EA, Lister JJ, Lundahl LH, Greenwald MK. 2018. Developing a scale of domains of negative consequences of chronic heroin use. Addict Behav. 77:260–266.
   PubMed Web of Science ®Google Scholar
• National Harm Reduction Coalition. 2020. Principles of harm reduction. [accessed 2020 Nov 16]. https://harmreduction.org/about-us/principles-of-harm-reduction/.
   Google Scholar
• O’Donnell J, Gladden RM, Mattson CL, Hunter CT, Davis NL. 2020. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants – 24 states and the District of Columbia, January-June 2019. Morb Mortal Wkly Rep. 69(35):1189–1197.
   PubMed Web of Science ®Google Scholar
• O’Rourke A, White RH, Park JN, Rodriguez K, Kilkenny ME, Sherman SG, Allen ST. 2019. Acceptability of safe drug consumption spaces among people who inject drugs in rural West Virginia. Harm Reduct J. 16(1):51.
   PubMed Web of Science ®Google Scholar
• Park JN, Sherman SG, Rouhani S, Morales KB, McKenzie M, Allen ST, Marshall BDL, Green TC. 2019. Willingness to use safe consumption spaces among opioid users at high risk of fentanyl overdose in Baltimore, Providence, and Boston. J Urban Health. 96(3):353–366.
   PubMed Web of Science ®Google Scholar
• Rigg KK, Monnat SM, Chavez MN. 2018. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 57:119–129.
   PubMed Web of Science ®Google Scholar
• Rudolph R, Allison S, Beatty J, Bisard W, Glair J, Hammon J, Hibbard T, Page C, Pemberton D, Sigman E. 2018. 2017 Jackson County drug-related data report. Heroin and Opioid Task Force Data Collection Committee. https://www.co.jackson.mi.us/DocumentCenter/View/6117/2_2018-Data-Report.
   Google Scholar
• Salmon AM, Dwyer R, Jauncey M, Van Beek I, Topp L, Maher L. 2009. Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend. 101(1–2):132–136.
   PubMed Web of Science ®Google Scholar
• Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. 2018. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV/AIDS Rep. 15(3):245–254.
   PubMed Web of Science ®Google Scholar
• Sobolewski JM, Amato PR. 2005. Economic hardship in the family of origin and children's psychological well‐being in adulthood. J Marriage and Family. 67(1):141–156.
   Web of Science ®Google Scholar
• Steele CB, Rim SH, Joseph DA, King JB, Seeff LC. 2013. Colorectal cancer incidence and screening-United States, 2008 and 2010. Morb Mortal Wkly Rep. 62(Suppl 3):53–60.
   Web of Science ®Google Scholar
• Strike C, Miskovic M. 2018. Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact. Harm Reduct J. 15(1):6– 15.
   PubMedGoogle Scholar
• Surratt HL, Cowley AM, Gulley J, Lockard SA, Otachi J, Rains R, Williams TR. 2020. Syringe service program use among people who inject drugs in Appalachian Kentucky. Am J Public Health. 110(1):34–36.
   PubMed Web of Science ®Google Scholar
• Tempalski B, Flom PL, Friedman SR, Des Jarlais DC, Friedman JJ, McKnight C, Friedman R. 2007. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health. 97(3):437–447.
   PubMed Web of Science ®Google Scholar
• Tempalski B, Friedman SR, Des Jarlais DC, McKnight C, Keem M, Friedman R. 2003. What predicts which metropolitan areas in the USA have syringe exchanges? Int J Drug Policy. 14(5–6):417–424.
   Google Scholar
• Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. 2006. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend. 83(3):193–198.
   PubMed Web of Science ®Google Scholar
• United States Census Bureau. 2020. QuickFacts: Jackson City, Michigan; [accessed 2021 May 10]. https://www.census.gov/quickfacts/fact/table/jacksoncitymichigan/LFE041219.
   Google Scholar
• Van Boekel LC, Brouwers EP, Van Weeghel J, Garretsen HF. 2013. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 131(1-2):23–35.
   PubMed Web of Science ®Google Scholar
• Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi AE, et al. 2016. County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States. J Acquir Immune Defic Syndr. 73(3):323–331.
   PubMed Web of Science ®Google Scholar
• Victor G, Kheibari A, Staton M, Oser C. 2018. Appalachian women's use of substance abuse treatment: examining the behavioral model for vulnerable populations. J Soc Work Pract Addict. 18(2):192–213.
   PubMed Web of Science ®Google Scholar
• Woodcock EA, Lundahl LH, Burmeister M, Greenwald MK. 2015. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: a pilot study. Am J Addict. 24(4):329–335.
   PubMed Web of Science ®Google Scholar
• Yang L, Wong LY, Grivel MM, Hasin DS. 2017. Stigma and substance use disorders: an international phenomenon. Curr Opin Psychiatry. 30(5):378–388.
   PubMed Web of Science ®Google Scholar
• Zibbell JE, Iqbal K, Patel RC, Suryaprasad A, Sanders KJ, Moore-Moravian L, Serrecchia J, Blankenship S, Ward JW, Holtzman D. 2015. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. Morb Mortal Wkly Rep. 64(17):453–458.
   PubMed Web of Science ®Google Scholar